Daxor Price to Book Ratio 2010-2011 | DXR
Historical price to book ratio values for Daxor (DXR) over the last 10 years. The current price to book ratio for Daxor as of July 11, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Daxor Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-11 | 9.29 | 1.08 | |
| 2011-12-31 | 8.59 | $8.62 | 1.00 |
| 2011-09-30 | 9.87 | $8.92 | 1.11 |
| 2011-06-30 | 9.51 | $10.79 | 0.88 |
| 2011-03-31 | 9.45 | $10.91 | 0.87 |
| 2010-12-31 | 8.52 | $11.12 | 0.77 |
| 2010-09-30 | 7.96 | $11.43 | 0.70 |
| 2010-06-30 | 8.51 | $13.62 | 0.62 |
| 2010-03-31 | 9.44 | $10.98 | 0.86 |
| 2009-12-31 | 10.09 | $11.21 | 0.90 |
| 2009-09-30 | 9.14 | $11.82 | 0.77 |
| 2009-06-30 | 7.89 | $10.60 | 0.74 |
| 2009-03-31 | 11.72 | $7.47 | 1.57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.046B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.140B | 18.86 |
| Encompass Health (EHC) | United States | $11.843B | 25.10 |
| DaVita (DVA) | United States | $10.831B | 15.23 |
| Elanco Animal Health (ELAN) | United States | $7.470B | 16.00 |
| Chemed (CHE) | United States | $6.813B | 21.41 |
| Option Care Health (OPCH) | United States | $4.993B | 22.25 |
| RadNet (RDNT) | United States | $4.314B | 273.81 |
| Amedisys (AMED) | United States | $3.205B | 21.56 |
| Addus HomeCare (ADUS) | United States | $2.064B | 22.67 |
| LifeStance Health (LFST) | United States | $1.839B | 0.00 |
| Astrana Health (ASTH) | United States | $1.436B | 35.57 |
| U.S Physical Therapy (USPH) | United States | $1.159B | 29.91 |
| Pennant (PNTG) | United States | $0.890B | 32.67 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.825B | 47.00 |
| Atai Life Sciences (ATAI) | Germany | $0.547B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Ontrak (OTRK) | United States | $0.002B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |